Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Not Yet Recruiting

ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS

NCT07617363

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

Phase I Study of FXS0683 in the Treatment of Blood Tumors

NCT07616089

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

U96-CAR-T-Cells For R/R B-ALL

NCT07511426

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)

NCT07607327

Conditions: AML (Acute Myelogenous Leukemia), Anemia, Anemia, Refractory, +16 more
Locations: CareDx, Inc. Brisbane, California, United States

View Trial Details

Not Yet Recruiting

FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML

NCT07598110

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

NCT07549464

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia

NCT07411586

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT06954987

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation

NCT07583303

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Not Yet Recruiting

Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission

NCT07577531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Leukemia

Leukemia trial results

Related conditions